BridgeBio Pharma Inc

NASDAQ:BBIO   3:59:59 PM EDT
39.69
+0.03 (+0.08%)
Debt Financing / Related, Mergers / Acquisitions

Eidos Therapeutics Inc Says On October 5 Bridgebio Pharma Inc Co Units Of Co Entered Into An Agreement And Plan Of Merger

Published: 10/07/2020 10:58 GMT
BridgeBio Pharma Inc (BBIO) - Eidos Therapeutics Inc - on October 5, Bridgebio Pharma, Inc. Co, Units of Co Entered Into an Agreement and Plan of Merger.
Eidos Therapeutics - Merger Agreement May Be Terminated Among Other Circumstances, by Either Party If Mergers Are Not Consummated by June 4, 2021.
Eidos Therapeutics - Upon Termination of Merger Agreement Under Certain Circumstances, Eidos Must Pay Bridgebio a Termination Fee of $35 Million.
Eidos Therapeutics - Upon Termination of Merger Agreement Under Certain Circumstances, Bridgebio Must Pay Eidos a Termination Fee of $100 Million.